Drug Type Small molecule drug |
Synonyms JDIC 127 |
Target |
Action inhibitors |
Mechanism TRPC5 inhibitors(Short transient receptor potential channel 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Anxiety Disorders | Preclinical | China | 01 Jan 2026 | |
| Anxiety Disorders | Preclinical | China | 01 Jan 2026 | |
| Depressive Disorder | Preclinical | China | 01 Jan 2026 | |
| Depressive Disorder | Preclinical | China | 01 Jan 2026 |





